Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
10.66
-0.18 (-1.62%)
Sep 23, 2026, 11:02 AM EDT - Market open
Novavax Market Cap
Novavax has a market cap or net worth of $1.76 billion as of September 23, 2026. Its market cap has increased by 21.99% in one year.
Market Cap
1.76B
Enterprise Value
1.34B
1-Year Change
21.99%
Ranking
Category
Stock Price
$10.66
ChartMarket Cap Chart
Since December 1, 1998, Novavax's market cap has increased from $25.70M to $1.76B, an increase of 6,738.51%. That is a compound annual growth rate of 16.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 1.76B | 60.94% |
| Dec 31, 2025 | 1.09B | -15.21% |
| Dec 31, 2024 | 1.29B | 125.87% |
| Dec 29, 2023 | 570.20M | -29.34% |
| Dec 30, 2022 | 807.00M | -92.54% |
| Dec 31, 2021 | 10.82B | 52.38% |
| Dec 31, 2020 | 7.10B | 6,609.55% |
| Dec 31, 2019 | 105.80M | -84.98% |
| Dec 31, 2018 | 704.40M | 81.13% |
| Dec 29, 2017 | 388.90M | 13.78% |
| Dec 30, 2016 | 341.80M | -84.90% |
| Dec 31, 2015 | 2.26B | 60.10% |
| Dec 31, 2014 | 1.41B | 32.47% |
| Dec 31, 2013 | 1.07B | 281.83% |
| Dec 31, 2012 | 279.60M | 92.96% |
| Dec 30, 2011 | 144.90M | -46.33% |
| Dec 31, 2010 | 270.00M | 8.56% |
| Dec 31, 2009 | 248.70M | 90.28% |
| Dec 31, 2008 | 130.70M | -36.71% |
| Dec 31, 2007 | 206.50M | -18.35% |
| Dec 29, 2006 | 252.90M | 33.74% |
| Dec 30, 2005 | 189.10M | 46.70% |
| Dec 31, 2004 | 128.90M | -28.82% |
| Dec 31, 2003 | 181.10M | 182.53% |
| Dec 31, 2002 | 64.10M | -80.46% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 1.81B |
| Septerna | 1.80B |
| Hemab Therapeutics Holdings | 1.77B |
| Tyra Biosciences | 1.76B |
| Nanobiotix | 1.73B |
| Intellia Therapeutics | 1.71B |
| Absci | 1.69B |
| Immunocore Holdings | 1.66B |